Intravenous Infusions PLC will hold its Annual General Meeting on August 8, 2025, at the University for Development Studies Guest House in Accra, where shareholders will vote on a proposed GH¢50 million rights issue for company recapitalization.
The pharmaceutical manufacturer announced the agenda includes approval of this capital raise as special business, alongside routine items like adoption of 2024 audited financial statements and director re-elections.
The meeting notice published in the Daily Graphic specifies the rights issue aims to strengthen the company’s financial position. Shareholders will also authorize the board to negotiate external auditor fees and approve directors’ remuneration. Proxy forms are accessible via the company’s website, with submissions accepted via email or physical delivery to GCB Bank’s share registry by August 7.
Founded in 1989 and based in Koforidua, the company specializes in medical products. The AGM occurs amid Ghana’s broader economic reforms under President Mahama’s administration, which emphasizes industrial resilience. Shareholders unable to attend may appoint proxies per Ghanaian corporate governance regulations.
